Range Cancer Therapeutics ETF: Historic Quarter Change, Sold Out
No data for this tab of Range Cancer Therapeutics ETF on this site yet.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| Tema Oncology ETF (CANC) | United States | $0.160B | 28.31% |
| Virtus Biotech Clinical Trials Etf (BBC) | United States | $0.037B | 19.29% |
| State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI) | United States | $7.434B | 18.16% |
| iShares Genomics Immunology and Healthcare ETF (IDNA) | United States | $0.160B | 16.04% |
| Principal Healthcare Innovators ETF (BTEC) | 15.36% | ||
| Defiance Nasdaq Junior Biotechnology ETF (IBBJ) | 15.10% | ||
| Direxion Daily S&P Biotech Bull 3X Shares (LABU) | United States | $0.519B | 14.27% |
| Virtus Biotech Etf (BBP) | United States | $0.059B | 12.98% |
| WisdomTree BioRevolution Fund (WDNA) | United States | $0.002B | 12.83% |
| iShares Biotechnology ETF (IBB) | United States | $8.123B | 10.69% |